Dysregulation of GRK2 levels has been implicated in the pathology of autoimmune diseases and cancer, suggesting that it plays a significant role in immune tolerance, inflammation, and the immune system's ability to combat malignancy. Here, GRK2 is linked to autoimmune disease.